Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    AUSTRALIA ANTIGEN
Show Display Options
Rank Status Study
1 Completed Optimization of Antiviral Therapy of Chronic HBV Infection
Conditions: Australia Antigen Positive;   Hepatitis B;   Adverse Effects
Intervention: Drug: Interferon Alfa-2a add on ADV
2 Completed A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Cyclophosphamide Doxorubicin Vincristine Lamivudine
3 Active, not recruiting Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
Condition: Hepatitis B
Interventions: Biological: Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.;   Biological: EngerixTM-B
4 Unknown  Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load
Condition: Chronic Hepatitis B
Intervention: Drug: Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
5 Completed Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
6 Recruiting Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
Condition: Hepatitis B
7 Completed
Has Results
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
Condition: Hepatitis B
Intervention: Procedure: Blood sampling
8 Completed Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers
Conditions: Active Immunity;   Healthy;   Stem Cell Transplantation
9 Completed
Has Results
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
Condition: Hepatitis B
Interventions: Biological: Engerix-B™;   Biological: Fendrix™;   Biological: GSK Biologicals' Hepatitis B vaccines (GSK223192A);   Biological: HBsAg (Booster injection)
10 Completed A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
Conditions: Hepatitis B;   Neoplasms
Intervention: Drug: Lamivudine
11 Completed Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers
Condition: Chronic Hepatitis B
Interventions: Drug: Vaccine+HBIG;   Drug: Vaccine+Placebo
12 Completed Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliovirus;   Haemophilus Influenzae Type b Disease
Interventions: Biological: DTPa-IPV/Hib vaccine;   Biological: EngerixTM-B;   Biological: DTPa-HBV-IPV/Hib vaccine
13 Recruiting Study of ARC-520 in Patients With Chronic Hepatitis B Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: ARC-520;   Drug: Placebo
14 Completed A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)
Condition: Bacterial Infections; Virus Diseases
Interventions: Biological: AR51 (12, 10);   Biological: PR51 (3, 10);   Biological: PR51 (6, 10);   Biological: PR51 (6, 15)
15 Completed Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients
Condition: Hepatitis B
Interventions: Biological: 1018 ISS immunostimulatory oligonucleotide with HBV surface antigen;   Biological: Hepatitis B Vaccine (Recombinant)
16 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
17 Completed Long-Term Lamivudine Therapy for Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Procedure: Blood Testing;   Procedure: Percutaneous Liver Biopsy;   Procedure: Lamivudine Therapy
18 Completed Integration of Family Planning and HIV Services in Tanzania
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Facilitated Referral
19 Completed Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
Condition: HIV Infections
Interventions: Biological: Tetanus Toxoid Vaccine;   Drug: Indinavir sulfate;   Drug: Lamivudine/Zidovudine;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Biological: Hepatitis B Vaccine (Recombinant);   Drug: Lamivudine;   Drug: Zidovudine
20 Completed Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
Condition: HIV Infections
Intervention: Drug: Tenofovir Disoproxil Fumarate

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years